MBAM
IRD icon

Mink Brook Asset Management’s Opus Genetics IRD Stock Holding History

Mink Brook Asset Management’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-161,205
Closed -$663K – 63
2026
Q2 		$663K Sell
161,205
-429,347
-73% -$2M 0.29% 39
2026
Q1 		$2.69M Sell
590,552
-1,075,079
-65% -$3.72M 1.5% 16
2025
Q4 		$3.35M Buy
1,665,631
+427,684
+35% +$868K 2.12% 13
2025
Q3 		$2.04M Buy
1,237,947
+40,331
+3% +$50.1K 1.38% 17
2025
Q2 		$1.13M Buy
1,197,616
+387,536
+48% +$359K 0.98% 16
2025
Q1 		$795K Buy
+810,080
New +$905K 0.84% 19

Other funds holding IRD

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return
BIOS Capital Management
BIOS Capital Management Fort Worth, Texas $34.2M AUM 13.29% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
AIC
AWM Investment Company New York $1.04B AUM 103.31% 1-Year Est. Return
Blue Owl Capital Holdings
Blue Owl Capital Holdings New York $548M AUM 35.34% 1-Year Est. Return
Affinity Asset Advisors
Affinity Asset Advisors New York $2.46B AUM 196.28% 1-Year Est. Return

Mink Brook Asset Management's IRD Position: Q3 2026 in Review

Mink Brook Asset Management sold out of Opus Genetics (IRD) in Q3 2026, closing a stake of 161,205 shares — an estimated $663K sold.

Mink Brook Asset Management first reported a position in IRD in Q1 2025 and held it in 6 quarters. The position peaked at $3.35M in Q4 2025. 74 funds tracked by Wall St. Rank hold IRD as of Q3 2026.

  • Mink Brook Asset Management reported no remaining Opus Genetics position as of Q3 2026 after selling out during the quarter.
  • Mink Brook Asset Management sold 161,205 Opus Genetics shares in Q3 2026, an estimated $663K.
  • Mink Brook Asset Management first reported a position in Opus Genetics in Q1 2025 and held it in 6 quarters.
  • Mink Brook Asset Management's Opus Genetics position peaked at $3.35M in Q4 2025.
  • 74 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2026.

Based on Mink Brook Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.